Showing 35,658 results

CROI 2023: Injeções trimestrais de PrEP podem ser eficazes para mulheres, Quinta-feira, 23 de fevereiro de 2023

February 2023
Combatting stigma

Silence Will Not Save You

Editor's pick
TheBody
23 February 2023
Injectable & long-acting HIV treatment

CROI 2023: Lenacapavir and two broadly neutralising antibodies for treatment Video

February 2023
Resistance

Treating HIV? Memorize These 12 HIV Resistance Mutations. Yes, Really.

Editor's pick
TheBodyPro
23 February 2023
Hepatitis B

ALLIANCE trial shows positive HIV/HBV coinfection treatment data

Editor's pick
Healio
23 February 2023
HIV in the arts & media

‘The First Fallen’ Review: A Remembrance of Those Passed

Editor's pick
The New York Times
23 February 2023
Injectable & long-acting PrEP

Modeling study shows that long-acting injectable cabotegravir has the potential to significantly reduce new HIV infections

Editor's pick
Clinton Health Access Initiative
23 February 2023
The search for an HIV prevention vaccine

A HIV Vaccine Candidate Demonstrates Its Safety and Capacity to Induce an Immune Response

Editor's pick
ANRS
23 February 2023
New & experimental HIV treatments

Merck Opens Enrollment in New Phase 3 Clinical Trials with Investigational Once-Daily Islatravir in Combination with Doravirine for Treatment of HIV-1 Infection

Editor's pick
Merck press release
23 February 2023
The search for a cure

The London Patient: ‘I feel like I won the lottery: I have been cured of two incurable diseases’

Editor's pick
El País
23 February 2023
Pharmaceutical industry

Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table

Editor's pick
FiercePharma
23 February 2023
Health problems in children & young people

Children's HIV Deaths in Africa Largely Preventable

Editor's pick
MedPage Today
23 February 2023
Infant feeding

U.S. Guidelines Embrace Breastfeeding as Option for Parents Living With HIV

Editor's pick
TheBodyPro
23 February 2023
Sex workers

Economic Empowerment Can Reduce HIV Along African Border Routes

Editor's pick
TheBody
23 February 2023
Access to healthcare

One year on: We must sustain the HIV response in Ukraine

Editor's pick
UNAIDS
23 February 2023
Injectable & long-acting HIV treatment

San Francisco shows that long-acting cabotegravir and rilpivirine may be feasible for people without viral suppression

News
23 February 2023
Injectable & long-acting HIV treatment

ViiV Healthcare announces positive data demonstrating long-acting injectable Cabenuva (cabotegravir, rilpivirine) is as effective as daily oral Biktarvy (BIC/FTC/TAF) for the treatment of HIV-1

Editor's pick
ViiV press release
23 February 2023
Access to healthcare

365 Days of War: Ukrainian HIV/TB Response Stands Strong!

Editor's pick
Alliance for Public Health
23 February 2023
History of HIV & AIDS

Largest ever collection of HIV/AIDS interviews revealed in London

Editor's pick
Evening Standard
23 February 2023
Weight gain & lipodystrophy

Switching to injectable cabotegravir and rilpivirine rarely affects body weight

News
23 February 2023
Access to healthcare

Sharing anti-HIV medication is common in rural Uganda

News
23 February 2023

CROI 2023: Quarterly injections of PrEP may be effective for women, Thursday 23 February 2023

February 2023
Mpox

First, second, and third generation smallpox vaccines all protect against mpox infection

News
23 February 2023
Changing treatment

Dolutegravir plus darunavir superior to three-drug darunavir combination in second-line treatment

News
23 February 2023